Dr. Reddys Laboratories is currently trading at Rs. 2997.00, down by 50.35 points or 1.65% from its previous closing of Rs. 3047.35 on the BSE. The scrip opened at Rs. 3000.00 and has touched a high and low of Rs. 3020.10 and Rs. 2941.00 respectively. So far 31951 shares were traded on the counter.
Lupin is currently trading at Rs. 1503.95, down by 16.35 points or 1.08% from its previous closing of Rs. 1520.30 on the BSE. The scrip opened at Rs. 1508.00 and has touched a high and low of Rs. 1520.00 and Rs. 1490.00 respectively. So far 79415 shares were traded on the counter.
Sun Pharmaceutical Industries is currently trading at Rs. 638.15, down by 9.55 points or 1.47% from its previous closing of Rs. 647.70 on the BSE. The scrip opened at Rs. 632.00 and has touched a high and low of Rs. 643.50 and Rs. 628.00 respectively. So far 197142 shares were traded on the counter.
Glenmark Pharmaceuticals is currently trading at Rs. 902.15, down by 2.00 points or 0.22 % from its previous closing of Rs. 904.15 on the BSE. The scrip opened at Rs. 897.00 and has touched a high and low of Rs. 905.00 and Rs. 889.95 respectively. So far 11381 shares were traded on the counter.
Pharma stocks came under pressure after US president-elect Donald Trump attacked the pharmaceutical industry for high drug prices and for manufacturing overseas, saying he will create new procedures for bidding on drugs, reports AFP. Trump also said the pharmaceutical companies are getting away with murder.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1665.25 |
| Dr. Reddys Lab | 1220.75 |
| Cipla | 1232.90 |
| Zydus Lifesciences | 928.85 |
| Lupin | 2311.75 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: